Respiratory diseases are a leading cause of death and disability globally, typically presenting in patients with existing comorbidities.
We work in close partnership with the Clinical Sciences Centre, and have extensive successful collaborations with external/industry partners. A central focus of research in the theme is to understand the role of microbiota in health and disease, exploiting cutting-edge techniques such a long-read metagenomics.
We collaborate with members across the Institute, with a broad interest in understanding how age and diabetes contribute to wound pathology. Our ultimate goal is to develop innovative new treatments for chronic wounds and respiratory illnesses that will bring clinical and economic benefits.